Abstract：
OBJECTIVE: Trigeminal neuralgia (TN) and trigeminal autonomic cephalalgias (TACs) are both painful diseases which directly impact the branches of the trigeminal nerve, which supply the face. Patients who have experienced adverse effects, have not responded to mainstream treatments, or have a personal preference for nonmedication options, often turn to complementary and integrative medicine (CIM). The aim of this review is to discuss the efficacy and safety of CIM therapies available for the treatment of TN and TACs.
RESULTS: Not only are there limited therapeutic options for TN and TAC patients, but also is there a proportion of patients who are intolerant to standard medical treatments. Recent findings have illustrated that 86% of patients with headache disorders utilize CIM modalities in combination with mainstream medical therapy. CIM modalities can be helpful for these diseases and have primarily been studied in combination with standard medical therapy. There is limited evidence for CIM and behavioral therapies in managing these conditions, and more research is needed to confirm which therapies are safe and effective.
RESULTS: Not only are there limited therapeutic options for TN and TAC patients, but also is there a proportion of patients who are intolerant to standard medical treatments. Recent findings have illustrated that 86% of patients with headache disorders utilize CIM modalities in combination with mainstream medical therapy. CIM modalities can be helpful for these diseases and have primarily been studied in combination with standard medical therapy. There is limited evidence for CIM and behavioral therapies in managing these conditions, and more research is needed to confirm which therapies are safe and effective.
摘要：
目的：三叉神经痛（TN）和三叉神经自主性头痛（TACs）都是直接影响三叉神经分支的疼痛疾病，供应脸。经历过不良反应的患者，对主流治疗没有反应，或者对非药物选择有个人偏好，经常转向补充和综合医学(CIM)。这篇综述的目的是讨论可用于治疗TN和TACs的CIM疗法的疗效和安全性。
结果：不仅TN和TAC患者的治疗选择有限，但也有一定比例的患者对标准药物治疗不耐受。最近的发现表明，86％的头痛患者将CIM模式与主流药物治疗相结合。CIM模式可能对这些疾病有帮助，并且主要与标准药物治疗相结合进行了研究。CIM和行为疗法在管理这些疾病方面的证据有限，需要更多的研究来确认哪些疗法是安全有效的。
结果：不仅TN和TAC患者的治疗选择有限，但也有一定比例的患者对标准药物治疗不耐受。最近的发现表明，86％的头痛患者将CIM模式与主流药物治疗相结合。CIM模式可能对这些疾病有帮助，并且主要与标准药物治疗相结合进行了研究。CIM和行为疗法在管理这些疾病方面的证据有限，需要更多的研究来确认哪些疗法是安全有效的。
